anti-CLDN18.2/anti-4-1BB bispecific antibody PM1032

{
  "id": "MLC-T-ONC-010510",
  "term": "anti-CLDN18.2/anti-4-1BB bispecific antibody PM1032",
  "field": "Oncology and biomedicine",
  "definition": "A bispecific antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform of claudin-18) and 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9; TNFRSF9), with potential immunostimulating and antineoplastic activities. Upon administration, anti-CLDN18.2/anti-4-1BB bispecific antibody PM1032 simultaneously targets and binds to CLDN18.2 expressed on tumor cells and 4-1BB expressed on a variety of leukocyte subsets including activated T lymphocytes. Upon CLDN18.2 binding and CLDN18.2-mediated crosslinking of 4-1BB, the 4-1BB activation signal is induced and PM1032 acts as a conditional 4-1BB agonist in the tumor microenvironment (TME), resulting in T-cell co-stimulation and T-lymphocyte-mediated anti-tumor activity. CLDN18.2, a tight junction protein and stomach-specific isoform of claudin-18, is expressed on a variety of tumor cells. Its expression in healthy tissues is strictly confined to short-lived differentiated epithelial cells of the gastric mucosa. 4-1BB, a surface glycoprotein of the tumor necrosis factor receptor superfamily, is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.",
  "synonyms": [
    "CLDN18.2/4-1BB bispecific antibody PM1032",
    "CLDN18.2 x 4-1BB bispecific antibody PM1032",
    "anti-CLDN18.2/4-1BB bispecific antibody PM1032"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-cldn18-2-anti-4-1bb-bispecific-antibody-pm1032/"
}